Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Consolidated net loss	$ (1,158,937)	$ (934,141)	$ (503,480)
Adjustments to reconcile net loss including noncontrolling interests to net cash and cash equivalents provided by operations:
Depreciation and amortization	208,142	130,083	75,622
Stock-based compensation expense	867,967	589,498	341,942
Operating lease non-cash expense	97,063	69,100	43,794
(Accretion)/amortization on marketable securities, net	(73,162)	0	0
Amortization of debt issuance costs	1,316	1,261	216
Impairment expense, (gain)/loss on investment and other asset sales, and other, net	8,969	361	680
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	(126,172)	(72,479)	(61,044)
Accounts payable	(3,475)	10,302	23,369
Prepaid expenses and other current assets	(12,770)	(33,769)	(13,593)
Other assets	(5,961)	(1,221)	(1,367)
Developer exchange liability	83,162	67,798	82,994
Accrued expenses and other current liabilities	8,680	19,560	58,809
Other long-term liability	11,397	10,159	(1,189)
Operating lease liabilities	(50,454)	(47,875)	(34,743)
Deferred revenue	742,294	662,378	819,927
Deferred cost of revenue	(139,879)	(101,719)	(172,828)
Net cash and cash equivalents provided by operating activities	458,180	369,296	659,109
Cash flows from investing activities:
Acquisition of property and equipment	(320,667)	(426,163)	(93,273)
Payments related to business combination, net of cash acquired	(3,859)	(13,388)	(45,692)
Purchases of intangible assets	(13,500)	(1,500)	(7,856)
Purchases of investments	(4,591,974)	0	0
Maturities of investments	1,642,719	0	0
Sales of investments	462,182	0	0
Net cash and cash equivalents used in investing activities	(2,825,099)	(441,051)	(146,821)
Cash flows from financing activities:
Proceeds from issuance of common stock	53,226	45,752	76,177
Net proceeds from issuance of preferred stock	0	0	534,286
Payment of withholding taxes related to net share settlement of restricted stock units	0	(150)	0
Proceeds from debt issuances	14,700	0	990,000
Payment of debt issuance costs	0	(154)	(2,339)
Payments related to business combination, after acquisition date	(750)	(150)	0
Other financing activities	0	(1,656)	0
Net cash and cash equivalents provided by financing activities	67,176	43,642	1,598,124
Effect of exchange rate changes on cash and cash equivalents	735	1,287	(55)
Net increase/(decrease) in cash and cash equivalents	(2,299,008)	(26,826)	2,110,357
Cash and cash equivalents
Beginning balance	2,977,474	3,004,300	893,943
Ending balance	678,466	2,977,474	3,004,300
Supplemental disclosure of cash flow information:
Cash paid for interest	38,750	38,965	0
Cash paid for income taxes, net	3,145	953	0
Supplemental disclosure of noncash investing and financing activities:
Property and equipment additions in accounts payable and accrued expenses and other current liabilities	31,340	57,199	50,388
Intangible asset purchases in accounts payable	1,200	0	0
Fair value of unregistered restricted stock awards issued as consideration for a business combination	0	10,138	31,274
Conversion of convertible preferred stock to common stock upon direct listing	0	0	879,113
Unpaid debt issuance costs	$ 0	$ 0	$ 154